260 followers
Using post-mortem brain tissue from Alzheimer's donors provided by BioIVT, the authors demonstrate that antibodies predicted to have a high affinity for AD Tau do not have expected efficacy to pathological Tau seeds. Read more. https://t.co/HbTirDoGtF